NDC 0002-3237

NDC 0002-3237

NDC 0002-3237 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 0002-3237
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 0002-3237-34 [00002323734]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-24
Marketing End Date2010-01-22

NDC 0002-3237-90 [00002323790]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-24
Marketing End Date2010-01-22

NDC 0002-3237-04 [00002323704]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-24
Marketing End Date2012-09-13

NDC 0002-3237-30 [00002323730]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-24
Marketing End Date2012-09-30

NDC 0002-3237-01 [00002323701]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-24
Marketing End Date2012-09-13

NDC 0002-3237-33 [00002323733]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-24
Marketing End Date2012-09-13

NDC 0002-3237-07 [00002323707]

Cymbalta CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA021427
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-26
Marketing End Date2012-09-30

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.